HPO
Db Link Name Definition Comment Is a
HPO HP:0410275 Lumbosacral hemangioma "A spinal cord hemangioma located in the lumbosacral spine region." [PMID:25449217] HP:0001028
HPO HP:0410276 Supraumbilical raphe "An abnormality of the sternum that presents at birth as a ventral sternal non-union defect, due to an abnormality of the fusion of the layers of the skin. It presents as a scar-like line that extends upward from the umbilicus (belly button)." [https://www.chw.org/medical-care/birthmarks-and-vascular-anomalies-center/conditions/phace-syndrome/phace-syndrome-handbook/ventral-or-midline-abnormalities, PMID:24075092] HP:0000766
HPO HP:0410277 Sternal pit "A sternal pit is a small indentation or dimple in the skin overlying the sternum of the chest. In some cases, the skin defect can be linear, extending several inches over the sternum." [https://www.chw.org/medical-care/birthmarks-and-vascular-anomalies-center/conditions/phace-syndrome/phace-syndrome-handbook/ventral-or-midline-abnormalities] HP:0000766
HPO HP:0410278 Pituitary gland cyst "A fluid-filled sacs that develop on or near the pituitary gland." [https://www.chop.edu/conditions-diseases/pituitary-cysts] HP:0010576
HPO HP:0410279 Atrophic pituitary gland "Partial or complete wasting (loss) of the pituitary gland." [DOI:10.1530/endoabs.44.EP82] HP:0012506
HPO HP:0410280 Pediatric onset "Onset of disease manifestations before adulthood, defined here as before the age of 15 years, but excluding neonatal or congenital onset." [ORCID:0000-0002-0843-4271] HP:0003674
HPO HP:0410281 Dyspepsia "A heterogeneous group of symptoms that are localized in the epigastric region. Typical dyspeptic symptoms include postprandial fullness, early satiation, epigastric pain and epigastric burning, but other upper gastrointestinal symptoms such as nausea, belching or abdominal bloating often occur." [PMID:23399526] HP:0002027
HPO HP:0410282 Abnormal circulating amylase level "A deviation from the normal concentration of amylase in the blood, an enzyme which helps digest glycogen and starch. It is produced mainly in the pancreas and salivary glands." [NCIT:C16284] HP:0010876
HPO HP:0410283 Positive blood acetaminophen test "Detection of acetaminophen in the blood." [] HP:0410172
HPO HP:0410284 Positive norpropoxyphene blood test "Detection of norpropoxyphene in the blood, a major metabolite of the opioid analgesic drug dextropropoxyphene." [PubChem:18804] HP:0410172
HPO HP:0410285 Positive meconium methadone test "Detection of methadone or its metabolite 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine (EDDP) in meconium." [] HP:0500098
HPO HP:0410286 Positive blood molindone test "Detection of molindone in the blood, an antipyschotic used for treatment of schizophrenia." [PubChem:23897] HP:0410172
HPO HP:0410287 Intrathoracic hemangioma "A hemangioma, a benign tumor of the vascular endothelial cells, that is located in the intrathoracic or chest region." [] HP:0001028
HPO HP:0410288 Hyperamylasemia "Increased level of amylase in the blood, an enzyme which helps digest glycogen and starch. It is produced mainly in the pancreas and salivary glands." [] HP:0410282
HPO HP:0410289 Hypoamylasemia "Decreased level of amylase in the blood, an enzyme which helps digest glycogen and starch. It is produced mainly in the pancreas and salivary glands." [] HP:0410282
HPO HP:0410290 Positive urine norpropoxyphene test "Detection of norpropoxyphene in urine." [] HP:0031840
HPO HP:0410291 Negativism "Opposing or not responding to instructions or external stimuli." [PMID:28754582, PMID:30262571] HP:0000708
HPO HP:0410292 Abnormal isohemagglutinin level "An abnormal level of isohemagglutinin in the blood. An isohemagglutinin refers to the naturally occurring antibodies in the ABO blood group system (i.e., anti-A in a group B person, anti-B in a group A person, and anti-A, anti-B, and anti-A,B in a group O person)." [] HP:0012475
HPO HP:0410293 Absent isohemagglutinin level "Absent or undetectable level of isohemagglutinin. An isohemagglutinin refers to the naturally occurring antibodies in the ABO blood group system (i.e., anti-A in a group B person, anti-B in a group A person, and anti-A, anti-B, and anti-A,B in a group O person)." [PMID:25309532] HP:0410292
HPO HP:0410294 Decreased specific antibody response to protein vaccine "A reduced ability to synthesize postvaccination antibodies against proteins in vaccines, as measured by antibody titer determination following vaccination." [PMID:26018535] HP:0032140
HPO HP:0410295 Complete or near-complete absence of specific antibody response to tetanus vaccine "The inability to synthesize postvaccination antibodies against a tetanus antigen, as measured by antibody titer determination following vaccination." [] HP:0410294
HPO HP:0410296 Complete or near-complete absence of specific antibody response to hepatitis B vaccine "The inability to synthesize postvaccination antibodies against a hepatisis B antigen, as measured by antibody titer determination following vaccination." [] HP:0410294
HPO HP:0410297 Partial absence of specific antibody response to tetanus vaccine "A reduced ability to synthesize postvaccination antibodies against a tetanus antigen, as measured by antibody titer determination following vaccination." [] HP:0410294
HPO HP:0410298 Partial absence of specific antibody response to hepatitis B vaccine "A reduced ability to synthesize postvaccination antibodies against a hepatitis B antigen, as measured by antibody titer determination following vaccination." [] HP:0410294
HPO HP:0410299 Decreased specific antibody response to polysaccharide vaccine "A reduced ability to synthesize postvaccination antibodies against polysaccharides in vaccines, as measured by antibody titer determination following vaccination." [PMID:26018535] HP:0032140